Trials / Completed
CompletedNCT01223924
Single-dose Escalation Trial of M2ES in Healthy Volunteer
Randomized ，Placebo-controlled,Single-dose Escalation Trial of M2ES in Healthy Volunteer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Protgen Ltd · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized double-blinded placebo-controlled，single-dose escalation trial in healthy volunteer.
Detailed description
Randomized double-blinded placebo-controlled，single-dose escalation trial in health volunteer,to determine the safety and the max tolerate dose in health volunteer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | placebo | placebo |
| DRUG | M2ES | M2ES IV 7.5mg-90mg |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2010-10-19
- Last updated
- 2010-10-19
Source: ClinicalTrials.gov record NCT01223924. Inclusion in this directory is not an endorsement.